Mintz, Levin, Cohn, Ferris, Glovsky and Popeo, P.C. advises on financing transactions, licensing collaborations, M&A, and public offerings, representing both entrepreneurs and venture-backed businesses as well as investors and underwriters. With a strong IP practice, it also handles patent prosecution, strategy, and litigation matters. The team is led by patent litigator and counselor Siegmund Gutman, who joined the Los Angeles office from Proskauer Rose LLP in May 2024, also bringing experience in Hatch-Waxman litigation and inter partes disputes. Also joining the LA office from Proskauer Rose LLP is David Hanna, an IP lawyer with expertise in patent prosecution, advice and litigation. Practice co-chair William Hicks, based in Boston, has extensive national and cross-border transactional experience.
L'éditorial du Legal 500
Distinctions
La satisfaction du client: Connaissance du secteur
Clients clés
- ArriVent BioPharma
- Pieris Pharmaceuticals, Inc.
- Amgen
- BeiGene, Ltd.
- F-star Therapeutics
- Johnson & Johnson
- QIAGEN N.V.
- Standard BioTools
- Fulgent Genetics
- Intra-Cellular Therapies Inc.
Points forts
Represented ArriVent BioPharma, Inc. in its $175M initial public offering, which was underwritten by Goldman Sachs, Jefferies, and Citigroup.
Represented Standard BioTools in its merger with SomaLogic.
Representing Amgen in a series of cases under the Biologics Price Competition and Innovation Act (BPCIA) to defend its Prolia and XGEVA franchises from biosimilar competition.
Responsable de la pratique
William Hicks; Siegmund Gutman
Autres avocats clés
Cheryl Reicin; John Rudy; David Hanna